A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders Protocol#6901
Natural History Study of Children with SCID (Severe Combined Immunodeficiency)
Sponsor: NIH
Enrolling: Male and Female Patients
IRB Number: AAAT3857
U.S. Govt. ID: NCT01186913
Contact: Olatundun Williams, MD: / ow2188@cumc.columbia.edu
Additional Study Information: This study is being done to identify the best outcomes for hematopoietic cell transplantation (HCT) or other treatment (enzyme replacement or gene therapy), which is life-saving therapy for children with SCID (severe combined immunodeficiency), leaky SCID, Omenn syndrome and reticular dysgenesis.
Olatundun Williams, MD
Do You Qualify?
Is your child under 18 years old? Yes No
Does your child have SCID (Severe Combined Immunodeficiency)? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Olatundun Williams, MD